CoChat

Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3 , the Human UNC-53 Homologue

Karenko, Leena, Hahtola, Sonja, Päivinen, Suvi, Karhu, Ritva, Syrjä, Sanna, Kähkönen, Marketta, Nedoszytko, Boguslaw, Kytölä, Soili, Zhou, Ying, Blazevic, Vesna, Pesonen, Maria, Nevala, Hanna, Nupponen, Nina, Sihto, Harri, Krebs, Inge, Poustka, Annemarie, Roszkiewicz, Jadwiga, Saksela, Kalle, Peterson, Pärt, Visakorpi, Tapio, Ranki, Annamari · 2005 · Cancer Research
Cited by 100

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Multicolor fluorescent in situ hybridization (FISH) was used to identify acquired chromosomal aberrations in 12 patients with mycosis fungoides or Sézary syndrome, the most common forms of primary cutaneous T-cell lymphoma (CTCL). The most frequently affected chromosome was 12, which showed clonal deletions or translocations with a break point in 12q21 or 12q22 in five of seven consecutive Sézary syndrome patients and a clonal monosomy in the sixth patient. The break point of a balanced translocation t(12;18)(q21;q21.2), mapped in the minimal common region of two deletions, fine mapped to 12q2. By locus-specific FISH, the translocation disrupted one gene, NAV3 (POMFIL1), a human homologue of unc-53 in Caenorhabditis elegans. A missense mutation in the remaining NAV3 allele was found in one of six cases with a deletion or translocation. With locus-specific FISH, NAV3 deletions were found in the skin lesions of four of eight (50%) patients with early mycosis fungoides (stages IA-IIA) and in the skin or lymph node of 11 of 13 (85%) patients with advanced mycosis fungoides or Sézary syndrome. Preliminary functional studies with lentiviral small interfering RNA-based NAV3 silencing in Jurkat cells and in primary lymphocytes showed enhanced interleukin 2 expression (but not CD25 expression). Thus, NAV3 may contribute to the growth, differentiation, and apoptosis of CTCL cells as well as to the skewing from Th1-type to Th2-type phenotype during disease progression. NAV3, a novel putative haploinsufficient tumor suppressor gene, is disrupted in most cases of the commonest types of CTCL and may thus provide a new diagnostic tool.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-0366

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 100

Metadata

Authors
Karenko, L., Hahtola, S., Päivinen, S., Karhu, R., Syrjä, S., Kähkönen, M., Nedoszytko, B., Kytölä, S., Zhou, Y., Blazevic, V., Pesonen, M., Nevala, H., Nupponen, N., Sihto, H., Krebs, I., Poustka, A., Roszkiewicz, J., Saksela, K., Peterson, P., Visakorpi, T., & Ranki, A.
Venue
Cancer Research
Published
2005-09-15
Volume
65
Issue
18
Pages
8101-8110
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2148724182
Cited by
100
References
1
FWCI
8.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3 , the Human UNC-53 Homologue. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-0366
The paper
Karenko, L., Hahtola, S., Päivinen, S., Karhu, R., Syrjä, S., Kähkönen, M., Nedoszytko, B., Kytölä, S., Zhou, Y., Blazevic, V., Pesonen, M., Nevala, H., Nupponen, N., Sihto, H., Krebs, I., Poustka, A., Roszkiewicz, J., Saksela, K., Peterson, P., . . . Ranki, A. (2005). Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3 , the Human UNC-53 Homologue. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-0366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.